ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,168Medicare Part D Prescriptions Filled, Including Refills

Rank: 371 out of 1499

$482K Total Retail Price of All Prescriptions

Rank: 356 out of 1499

334 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 7,662 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
LEVOTHYROXINE SODIUM 396 339 1 2
FUROSEMIDE 368 344 2 7
POTASSIUM CHLORIDE 316 290 3 11
OMEPRAZOLE 282 203 4 5
TRAMADOL HCL 241 192 5 16
WARFARIN SODIUM 226 220 6 12
HYDROCODONE-ACETAMINOPHEN 219 165 S3 7 4
GABAPENTIN 195 157 8 13
LISINOPRIL 190 177 9 1
CITALOPRAM HBR 174 137 10 14
METOPROLOL TARTRATE 141 132 11 10
MELOXICAM 129 123 12 27
SIMVASTATIN 129 102 12 3
QUINAPRIL HCL 125 113 14 125
PRAVASTATIN SODIUM 123 93 15 18
METOPROLOL SUCCINATE 115 115 16 20
AMLODIPINE BESYLATE 111 109 17 6
POLYETHYLENE GLYCOL 3350 110 98 18 52
DIGOXIN 101 85 19 56
LOSARTAN POTASSIUM 100 93 20 26
METFORMIN HCL 98 65 21 8
ROPINIROLE HCL 95 67 22 55
ATORVASTATIN CALCIUM 93 84 23 17
ZOLPIDEM TARTRATE 92 67 24 23
SERTRALINE HCL 89 86 25 24
NEXIUM 88 66 26 28
FENTANYL 88 54 S2 26 60
RANITIDINE HCL 88 84 26 15
GLIMEPIRIDE 87 60 29 38
MIRTAZAPINE 81 69 30 50
ALENDRONATE SODIUM 79 79 31 33
HYDROCHLOROTHIAZIDE 76 65 32 9
CYMBALTA 76 32 32 40
ATENOLOL 75 55 34 21
NAMENDA 74 74 35 47
FINASTERIDE 72 70 36 98
TAMSULOSIN HCL 70 59 37 29
METFORMIN HCL ER 66 66 38 53
LANTUS 63 50 39 46
DONEPEZIL HCL 62 57 40 35
PANTOPRAZOLE SODIUM 59 58 41 48
ADVAIR DISKUS 59 50 41 37
ESCITALOPRAM OXALATE 58 53 43 76
IPRATROPIUM-ALBUTEROL 57 56 44 161
CARVEDILOL 55 52 45 22
FLUTICASONE PROPIONATE 52 38 46 31
CRESTOR 50 50 47 34
ALBUTEROL SULFATE 50 50 47 152
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 31, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.